Recent in Claims/Labeling (page 5 of 5)
Apr 24, 2013
Claims for hair products generally are not associated with clear cut outcomes. Therefore, consumers have no standard by which to compare product efficacy. In relation, the North American Hair Research Society (NAHRS) has proposed standards for hair product claims, outlined here, which relate to characteristics including frizz, color fastness and curl retention, among others.
Apr 18, 2013
Substantial evidence, which the FDA requires to support claims for drugs, is applicable to personal care, especially considering the pharmaceutical direction products have taken. The present article considers whether the industry is benefiting from marketing without assuming the responsibility for potential effects. In addition, it considers the limitations of in vitro and in vivo test models.
Nov 29, 2012 | Cosmetics & Toiletries Staff
On Nov. 28, 2012, Cosmetics & Toiletries hosted a live Webinar titled, "Regulations—What You Forgot to Ask," featuring a call-in with industry regulatory expert David Steinberg.
Sep 19, 2012
The US Food and Drug Administration (FDA) has issued a warning letter to L'Oréal for gene, stem cell and skin regeneration claims associated with Lancôme products.
Jun 4, 2012 | David C. Steinberg, Steinberg Consultants
On March 11, 2003, the European Union (EU) published the 7th Amendment to its Cosmetic Directive 76/768/EEC. Among the changes was the addition of the 26 popular fragrance ingredients to the Annex III “List of Substances Which Cosmetic Products Must Not Contain Except Subject to the Restrictions Laid Down.” These are now commonly referred to as the EU Fragrance Allergens.